RECBIO's new drug application for REC610 has been accepted

阿斯達克財經網
2025.12.29 16:47
瑞科生物－B(02179.HK) 公佈，公司新佐劑重組帶狀皰疹疫苗 REC610 的新藥上市申請獲國家藥品監督管理局藥品審評中心正式受理。目前，全球範圍內新佐劑重組帶狀皰疹疫苗僅有葛蘭素史克 Shingrix 上市銷售。
Source: 阿斯達克財經網 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.